Oruka Therapeutics (ORKA) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.76% |
| Dec 31, 2025 | 68.82% |
| Sep 30, 2025 | 90.82% |
| Jun 30, 2025 | 70.72% |
| Mar 31, 2025 | 73.89% |
| Dec 31, 2024 | 74.54% |
| Sep 30, 2024 | 74.11% |
| Jun 30, 2024 | -21.00% |
| Mar 31, 2024 | -18.10% |
| Dec 31, 2023 | -16.06% |
| Sep 30, 2023 | -14.83% |
| Jun 30, 2023 | -12.42% |
| Mar 31, 2023 | -10.71% |
| Dec 31, 2022 | -9.86% |
| Sep 30, 2022 | -8.97% |
| Jun 30, 2022 | -7.28% |
| Mar 31, 2022 | -6.13% |
| Dec 31, 2021 | -6.17% |
| Sep 30, 2021 | -7.00% |
| Jun 30, 2021 | -9.95% |
| Mar 31, 2021 | 2.38% |
| Dec 31, 2020 | -5.59% |
| Sep 30, 2020 | -20.25% |
| Jun 30, 2020 | -18.80% |
| Mar 31, 2020 | -21.71% |
| Dec 31, 2019 | -22.60% |
| Sep 30, 2019 | -17.40% |
| Jun 30, 2019 | -14.83% |
| Mar 31, 2019 | -6.08% |
| Dec 31, 2018 | -3.71% |
| Sep 30, 2018 | 1.44% |
| Jun 30, 2018 | 9.46% |
| Mar 31, 2018 | 10.96% |
| Dec 31, 2017 | 12.80% |
| Sep 30, 2017 | 7.78% |
| Jun 30, 2017 | 4.66% |
| Mar 31, 2017 | 2.56% |
| Dec 31, 2016 | 0.00% |
| Sep 30, 2016 | -16.10% |
| Jun 30, 2016 | -31.12% |
| Dec 31, 2015 | -47.32% |